Elevated CEA level is an important determinant of CRC in which CEA level ≥5 was 2.3 times a higher hazard to death than patients with those<5 ng/ml (AHR: 2.3, CI: 1.1–5). This evidence concerns the gene CEACAM5 and colorectal carcinoma.